Methscopolamine Bromide
6 NDCs across 3 manufacturers|6 Generic,0 Brand
Methscopolamine Bromide is used to treat peptic ulcer, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $665K on Methscopolamine Bromide across 4,857 claims for 1,569 beneficiaries.
Methscopolamine Bromide is available as 6 NDCs from 3 manufacturers (6 generic, 0 brand), with NADAC prices from $0.61 to $1.53 per EA — the most expensive product costs about 2.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
6G / 0B
Manufacturers
3
competing in market
Price Spread
$0.61 – $1.53
per EA
7d Activity
avg +6.5% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Breckenridge Pharmaceutical Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Anticholinergic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
3 manufacturers producing METHSCOPOLAMINE BROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
METHSCOPOLAMINE BROM 5 MG TAB | $1.5316 per EA | +2.76% |
METHSCOPOLAMINE BROM 5 MG TAB | $1.5316 per EA | +2.76% |
METHSCOPOLAMINE BROM 5 MG TAB | $1.5316 per EA | +2.76% |
METHSCOPOLAMINE BROM 2.5 MG TB | $0.6076 per EA | +10.34% |
METHSCOPOLAMINE BROM 2.5 MG TB | $0.6076 per EA | +10.34% |
METHSCOPOLAMINE BROM 2.5 MG TB | $0.6076 per EA | +10.34% |
Frequently Asked Questions
What is Methscopolamine Bromide used to treat?
Methscopolamine Bromide is used to treat peptic ulcer, per the National Library of Medicine's MED-RT classification.
When did Methscopolamine Bromide become available as a generic?
FDA approved the first generic Methscopolamine Bromide (ANDA) on Jan 1, 1982.
How much does Medicare spend on Methscopolamine Bromide?
In 2024, Medicare Part D spent $665K on Methscopolamine Bromide across 4,857 claims for 1,569 beneficiaries.
How many Methscopolamine Bromide products are on the market?
The Methscopolamine Bromide drug market contains 6 NDCs from 3 manufacturers — 6 generic and 0 brand products.
What is the price range for Methscopolamine Bromide?
NADAC reference prices for Methscopolamine Bromide range from $0.6076 to $1.5316 per EA — the most expensive product costs about 2.5× the cheapest.
Which manufacturers make Methscopolamine Bromide?
3 manufacturers list Methscopolamine Bromide in NADAC. Ranked by number of NDCs, the largest are Breckenridge Pharmaceutical Inc. (2), i3 Pharmaceuticals, LLC (2), Unichem Pharmaceuticals (USA) Inc. (2).
How has the price of Methscopolamine Bromide changed recently?
Over the past 7 days, 6 Methscopolamine Bromide NDCs rose and 0 fell, with a market-wide average change of +6.5%.